International Stem Cell Corp. (ISCO) Poster Selected for Presentation at American Association for the Study of Liver Diseases Meeting
The American Association for the Study of Liver Diseases (AASLD) recently highlighted International Stem Cell’s presentation, titled "Human parthenogenetic stem cell-derived hepatocyte transplantation controls serum bilirubin in Gunn rats," as a Presidential Poster of Distinction at The Liver Meeting during the four-day AASLD'S 64th Annual Meeting in Washington, D.C. The presentation authors are Dr. Alina Ostrowska, Dr. Larisa Agapova, Tiffany Chu, Dr. Trudy Christiansen-Weber and Dr. Ruslan Semechkin, all of which are from International Stem Cell. International Stem Cell is a development stage biotech company focused on therapeutic applications of human stem cells as well as the development and commercialization…